|Net Assets||9.50 Bil|
- Last NAV update 12/12/2013 4:00 PM ET
|The investment seeks long-term capital appreciation. The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. It also considers companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks.|
- Year to date performance as of 12/12/2013 12:00 AM ET
|Fund Manager||Jean Hynes|
|Minimum Initial Purchase||3,000.00|
|Minimum IRA Investment||NA|
- * Annualized returns
- Performance as of 12/12/2013 12:00 AM ET
|Net Assets||9.50 Bil||693.18 Mil|
|Avg Market Cap||31.62 Bil||24.01 Bil|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.